# causality-assessment-api

from the [paper](https://reader.elsevier.com/reader/sd/pii/S0933365717306152?token=7C9DD4DB0AAA4D2C980DC907F0862DC8462D0E70F0E5525BCB87C73FE6AFE2B3D3A843466442383E581BED5FF4B39CFF&originRegion=eu-west-1&originCreation=20221205142619):
https://reader.elsevier.com/reader/sd/pii/S0933365717306152?token=7C9DD4DB0AAA4D2C980DC907F0862DC8462D0E70F0E5525BCB87C73FE6AFE2B3D3A843466442383E581BED5FF4B39CFF&


```The nomenclature used for drug classification was the
one adopted by Portuguese Authority of Medicines and Health Products
(INFARMED, IP) according to national legislation (Despacho no 21844/
2004, de 12 de outubro) which includes a correspondence with the in-
ternational ATC. Variable modeled with (anti-infectious/central ner-
vous system/cardiovascular system/blood/respiratory system/gastro-
intestinal system/genitourinary system/hormones and drugs used to
treat endocrine diseases/loco-motor system/anti-allergic medication/
nutrition/corrective agents in blood volume and electrolyte dis-
turbances/ drugs for skin disorders/drugs used in otorhinolar-
yngological disorders/drugs for eye disorders/antineoplastic drugs and
immune-modulators/drugs used to treat poisoning/vaccines and im-
munoglobulins/diagnosis media)
```
